Stay updated with breaking news from Ino morea news. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a report released on Monday. Several other research analysts have also weighed in on the company. Oppenheimer upgraded Inovio Pharmaceuticals from a market perform rating to an outperform rating and set a $4.00 target price on […] ....
Quirky rom-com Amélie felt like a breath of fresh air when it was released two decades ago. It's just as relevant today, but for different reasons ....